91510-63-3

Upstream product

• 39697-97-7 4-O-Allyl-1,6-anhydro-2-O-tosyl-β-D-glucopyranose 
• 3868-03-9 1,6:2,3-dianhydro-β-D-mannopyranose 
• 106-95-6 allyl bromide 
• 13265-84-4 D-glucal 
• 6167-32-4 1,6:3,4-dianhydro-2-O-tosyl-D-galactose 
• 139437-39-1 1,6-anhydro-2-deoxy-2-iodo-β-D-glucopyranose 
• 107-18-6 allyl alcohol 
• 498-07-7 levoglucosan 

Downstream Products

• 97321-52-3 C₁₅H₁₈O₄ 
• 81076-80-4 1,6-anhydro-2-desoxy-2,4-di-C-methyl-3-O-benzyl-4-O-mesyl-β-D-galactopyranose 
• 97321-57-8 1,6-anhydro-2-desoxy-2,4-di-C-methyl-3,5-di-O-benzyl-α-L-idofuranose 
• 97321-49-8 1,6-anhydro-2-desoxy-2,4-di-C-methyl-3-O-benzyl-5-O-mesyl-α-L-idofuranose 
• 97321-56-7 1,6-anhydro-2-desoxy-2,4-di-C-methyl-3-O-benzyl-α-L-idofuranose 
• 85263-98-5 1,6-anhydro-3-O-benzyl-2-deoxy-2,4-di-C-methyl-α-D-galactofuranose 
• 97321-58-9 1,6-anhydro-2-desoxy-2,4-di-C-methyl-3-O-benzyl-β-L-idopyranose 
• 97321-54-5 1,6-anhydro-3-O-benzyl-2-deoxy-2,4-di-C-methyl-β-D-allopyranose 
• 98119-48-3 1,6-anhydro-3-O-benzyl-2-deoxy-2,4-di-C-methyl-β-D-glucopyranose 
• 97321-51-2 1,6-anhydro-3-O-benzyl-2-deoxy-2-C-methyl-4-methylene-β-D-ribo-hexopyranose 
• 97321-52-3 C₁₅H₁₈O₄ 
• 91510-66-6 1,6-anhydro-3-O-benzyl-2-deoxy-2-C-methyl-β-D-ribo-hexopyranos-4-ulose 
• 123493-62-9 1,6-anhydro-2,3-didesoxy-2,4-di-C-methyl-4-O-benzyl-β-D-galactopyranose 
• 81076-78-0 1,6-anhydro-2-desoxy-2,4-di-C-methyl-4-O-benzyl-β-D-galactopyranose 

Relevant academic research and scientific papers

A facile synthesis of Cerny epoxides and selectively blocked derivatives of 2-azido-2-deoxy-β-D-glucopyranose

1,6:2,3-Dianhydro-β-D-glucopyranose and its 3-alkylated derivatives were prepared from D-glucal in one pot with overall isolated yields of 60-70%, and these Cerny epoxides were further conveniently converted to selectively blocked 2-azido-2-deoxy-β-D-glucopyranose derivatives by azido opening of the epoxide ring.

Synthesis and biological activity of oligomer-model compounds containing units of a key platelet-binding disaccharide of heparin

A key disaccharide unit in heparin, O-(2-deoxy-2-sulfamido-6-O-sulfo-α-D-glucopyranosyl)-(1→4)-2-O-sulfo-α-L-idop yranosyluronic acid, was previously found to be responsible for the binding interaction of heparin to platelets. A clustering effect to enhance the binding was found to be dependent on the number and frequency of the disaccharide units in a heparin molecule. To systematically examine the clustering effect, three oligomer-model compounds containing two or three units of the disaccharide were synthesized. These compounds inhibited 3H-labelled heparin binding to human platelets more strongly than a compound containing only one unit of the disaccharide.

Opening of levoglucosane derived epoxides with oxygen, nitrogen and sulfur nucleophiles

A variety of nucleophiles were employed to open levoglucosane derived epoxides.